Literature DB >> 10936134

Outpatient pleurodesis of malignant pleural effusions using a small-bore pigtail catheter.

L Saffran1, D E Ost, A M Fein, M J Schiff.   

Abstract

STUDY
OBJECTIVE: Patients with symptomatic malignant pleural effusion are usually treated with large-bore chest tube placement and pleurodesis requiring > or = 3 days of hospitalization. We sought to demonstrate the feasibility of ambulatory drainage and sclerosis using a small-bore pigtail catheter in patients with malignant pleural effusions. We reasoned that this approach would improve symptoms and quality of life at a reduced cost.
METHODS: A 14F pigtail catheter was percutaneously inserted into the pleural space and connected to a closed gravity-drainage bag system. The patients were instructed in the use of the drainage system and discharged to return for sclerosis with 4 g of talc after the drainage was < 100 mL/24 h. Patients were graded for dyspnea and performances status using the Eastern Cooperative Oncology Group score (ECOG) and baseline and transitional dyspnea index score (BDI-TDI) before tube placement and again at 30 days. Radiographic response was graded as total response, partial response, or failure. Telephone follow-up was initiated when the patient could not return for evaluation.
RESULTS: Ten ambulatory women, ages 41 to 79 years, were enrolled. The chest tube was left in place from 1 to 10 days, draining a mean of 2,956 mL (1,685 to 6,050 mL). Only two patients were unable to undergo sclerosis owing to catheter dislodgment and minimal drainage. Six reported symptomatic improvement at 30 days confirmed by TDI and ECOG scores in four of six. One with a prior history of a lobectomy was found to have a chylous pleural effusion and experienced a hydropneumothorax, for which sclerosis was unsuccessful. One died in hospital on day 26 after sclerosis despite radiographic resolution. Of the four patients who had improved dyspnea and functional status by TDI and EGOG scores, radiographic response was complete in three and partial in one. Two of the six were not able to return for follow-up because of weakness but reported improvement by telephone inquiry.
CONCLUSION: Ambulatory sclerosis of malignant effusion using a small-bore catheter is a feasible alternative to inpatient sclerosis with a large-bore chest tube, especially in patients with strong preferences for outpatient care.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10936134     DOI: 10.1378/chest.118.2.417

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  16 in total

1.  Current dyspnea among long-term survivors of early-stage non-small cell lung cancer.

Authors:  Marc B Feinstein; Paul Krebs; Elliot J Coups; Bernard J Park; Richard M Steingart; Jack Burkhalter; Amy Logue; Jamie S Ostroff
Journal:  J Thorac Oncol       Date:  2010-08       Impact factor: 15.609

2.  Percutaneous management of malignant fluid collections.

Authors:  Leann S Stokes
Journal:  Semin Intervent Radiol       Date:  2007-12       Impact factor: 1.513

3.  Successful use of central venous catheters in the management of recurrent malignant pleural effusions: one new option.

Authors:  Abbas Yazdanbod; Azita Salehifar; Nasrollah Maleki; Shahram Habibzadeh; Zahra Tavosi
Journal:  Support Care Cancer       Date:  2015-01-10       Impact factor: 3.603

4.  Sodium hydroxide as a sclerosing agent in patients with neoplastic pleural effusion non-candidates for VATS: results of a minimally invasive protocol.

Authors:  Micaela Raices; Matías E Czerwonko; Agustin Dietrich; Alejandro Da Lozzo; Enrique Beveraggi; David Smith
Journal:  Updates Surg       Date:  2017-08-31

5.  Pleurodesis with povidone-iodine, as an effective procedure in management of patients with malignant pleural effusion.

Authors:  Gholamali Godazandeh; Nasim Haji Qasemi; Mohammad Saghafi; Meisam Mortazian; Pouya Tayebi
Journal:  J Thorac Dis       Date:  2013-04       Impact factor: 2.895

6.  Application of ultrasound-guided pigtail catheter for drainage of pleural effusions in the ICU.

Authors:  Shinn-Jye Liang; Chih-Yen Tu; Hung-Jen Chen; Chia-Hung Chen; Wei Chen; Chuen-Ming Shih; Wu-Huei Hsu
Journal:  Intensive Care Med       Date:  2008-10-11       Impact factor: 17.440

7.  Efficacy of medical thoracoscopic talc pleurodesis in malignant pleural effusion caused by different types of tumors and different pathological classifications of lung cancer.

Authors:  Juan Chen; Zhu Li; Ning Xu; Xin Zhang; Yu Wang; Dianjie Lin
Journal:  Int J Clin Exp Med       Date:  2015-10-15

8.  Treatment of malignant pleural effusion: a cost-effectiveness analysis.

Authors:  Varun Puri; Tanya L Pyrdeck; Traves D Crabtree; Daniel Kreisel; Alexander S Krupnick; Graham A Colditz; G Alexander Patterson; Bryan F Meyers
Journal:  Ann Thorac Surg       Date:  2012-05-10       Impact factor: 4.330

9.  Effectiveness and safety of outpatient pleurodesis in patients with recurrent malignant pleural effusion and low performance status.

Authors:  Ricardo Mingarini Terra; Lisete Ribeiro Teixeira; Benoit Jacques Bibas; Paulo Manuel Pego-Fernandes; Francisco Suso Vargas; Fabio Biscegli Jatene
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

10.  Mitoxantrone pleurodesis to palliate malignant pleural effusion secondary to ovarian cancer.

Authors:  Nikolaos Barbetakis; Michalis Vassiliadis; Konstantinos Kaplanis; Rosalia Valeri; Christodoulos Tsilikas
Journal:  BMC Palliat Care       Date:  2004-09-09       Impact factor: 3.234

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.